Research ArticleClinical Studies
Change in Serum Lactate Dehydrogenase Is Associated with Outcome of Patients with Advanced-stage NSCLC Treated with Erlotinib
ONDREJ FIALA, MILOS PESEK, JINDRICH FINEK, ONDREJ TOPOLCAN, JAROSLAV RACEK, MARTIN SVATON, RADEK KUCERA, MAREK MINARIK, LUCIE BENESOVA, ZBYNEK BORTLICEK, RENATA CHLOUPKOVA, ALEXANDR POPRACH and TOMAS BUCHLER
Anticancer Research May 2016, 36 (5) 2459-2465;
ONDREJ FIALA
1Department of Oncology and Radiotherapy, Medical School and Teaching Hospital in Pilsen, Charles University in Prague, Prague, Czech Republic
2Biomedical Center, Faculty of Medicine in Pilsen, Charles University in Prague, Prague, Czech Republic
MILOS PESEK
3Department of Pneumology, Medical School and Teaching Hospital in Pilsen, Charles University in Prague, Prague, Czech Republic
JINDRICH FINEK
1Department of Oncology and Radiotherapy, Medical School and Teaching Hospital in Pilsen, Charles University in Prague, Prague, Czech Republic
ONDREJ TOPOLCAN
4Department of Nuclear Medicine, Medical School and Teaching Hospital in Pilsen, Charles University in Prague, Prague, Czech Republic
JAROSLAV RACEK
5Istitute of Clinical Biochemistry and Hematology, Medical School and Teaching Hospital in Pilsen, Charles University in Prague, Prague, Czech Republic
MARTIN SVATON
3Department of Pneumology, Medical School and Teaching Hospital in Pilsen, Charles University in Prague, Prague, Czech Republic
RADEK KUCERA
4Department of Nuclear Medicine, Medical School and Teaching Hospital in Pilsen, Charles University in Prague, Prague, Czech Republic
MAREK MINARIK
6Center for Applied Genomics of Solid Tumours, Genomac Research Institute, Prague, Czech Republic
7Department of Analytical Chemistry, Faculty of Sciences, Charles University in Prague, Prague, Czech Republic
LUCIE BENESOVA
6Center for Applied Genomics of Solid Tumours, Genomac Research Institute, Prague, Czech Republic
ZBYNEK BORTLICEK
8Institute of Biostatistics and Analysis, Faculty of Medicine, Masaryk University, Brno, Czech Republic
RENATA CHLOUPKOVA
8Institute of Biostatistics and Analysis, Faculty of Medicine, Masaryk University, Brno, Czech Republic
ALEXANDR POPRACH
9Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute and Faculty of Medicine, Masaryk University, Brno, Czech Republic
TOMAS BUCHLER
10Department of Oncology and First Faculty of Medicine, Charles University and Thomayer Hospital, Prague, Czech Republic
In this issue
Change in Serum Lactate Dehydrogenase Is Associated with Outcome of Patients with Advanced-stage NSCLC Treated with Erlotinib
ONDREJ FIALA, MILOS PESEK, JINDRICH FINEK, ONDREJ TOPOLCAN, JAROSLAV RACEK, MARTIN SVATON, RADEK KUCERA, MAREK MINARIK, LUCIE BENESOVA, ZBYNEK BORTLICEK, RENATA CHLOUPKOVA, ALEXANDR POPRACH, TOMAS BUCHLER
Anticancer Research May 2016, 36 (5) 2459-2465;
Change in Serum Lactate Dehydrogenase Is Associated with Outcome of Patients with Advanced-stage NSCLC Treated with Erlotinib
ONDREJ FIALA, MILOS PESEK, JINDRICH FINEK, ONDREJ TOPOLCAN, JAROSLAV RACEK, MARTIN SVATON, RADEK KUCERA, MAREK MINARIK, LUCIE BENESOVA, ZBYNEK BORTLICEK, RENATA CHLOUPKOVA, ALEXANDR POPRACH, TOMAS BUCHLER
Anticancer Research May 2016, 36 (5) 2459-2465;
Jump to section
Related Articles
- No related articles found.